Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real World Multicenter 48 Week Prospective Cohort Study to Capture Clinical and Patient Centered Outcomes in Adults With Severe Eosinophilic Asthma Treated With Benralizumab in Routine Care Settings in Greece

NCT05440656 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05440656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05440656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real World Multicenter 48 Week Prospective Cohort Study to Capture Clinical and Patient Centered Outcomes in Adults With Severe Eosinophilic Asthma Treated With Benralizumab in Routine Care Settings in Greece
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 29, 2022
Completion date
April 13, 2025
Enrollment
152 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

severe eosinophilic asthma